Weimin Zhu

发表

Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors

J. Doroshow, A. Chen, E. Polley, 2015, Investigational New Drugs.

Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression

Q. Pan, Weimin Zhu, Hao Yu, 2016, Tumor Biology.

Chemical library screen for novel inhibitors of Kaposi's sarcoma-associated herpesvirus processive DNA synthesis.

R. Shoemaker, R. Ricciardi, S. Sei, 2006, Antiviral research.

Potent Antiviral Activity of North-Methanocarbathymidine against Kaposi's Sarcoma-Associated Herpesvirus

R. Shoemaker, S. Sei, Paula E Roberts, 2005, Antimicrobial Agents and Chemotherapy.

Discovery of Small-Molecule Human Immunodeficiency Virus Type 1 Entry Inhibitors That Target the gp120-Binding Domain of CD4

Robert H. Shoemaker, Andrew G. Stephen, Robert J. Gorelick, 2005, Journal of Virology.

MicroRNA-98 Suppress Warburg Effect by Targeting HK2 in Colon Cancer Cells

Q. Pan, Weimin Zhu, Hao Yu, 2017, Digestive Diseases and Sciences.

Construction and Validation of a Novel Web-Based Nomogram for Solitary Plasmacytoma of Bone of the Spine: A Real-World Analysis Based on the Surveillance, Epidemiology, and End Results Database.

Zhengwang Sun, Weimin Zhu, Mengchen Yin, 2023, World neurosurgery.

Abstract A106: Investigation of 5-fluorodeoxycytidine with tetrahydrouracil as a demethylation regimen in solid tumors.

J. Doroshow, R. Parchment, S. Kummar, 2011 .

Interference with thymocyte differentiation by an inhibitor of S-adenosylhomocysteine hydrolase.

W. Zhu, A. Cohen, Weimin Zhu, 1995, Journal of immunology.